Embargoed Release: 07:00hrs Tuesday 10 June 2008
SOPHEON PLC
(`Sopheon')
AGM Statement
At the Annual General Meeting of Sopheon plc to be held later today, the
chairman of the board will give shareholders an update and review of the
business. This will include the following statement:
"As noted in our annual report, 2007 was a year of steady progress. Revenues
grew to £6.3 million, and we achieved a positive EBITDA result for the second
year running. In the first months of 2008, we have continued to move forward.
Although our revenue growth in 2007 was modest compared to 2006, I am pleased
to announce that today, revenue visibility from contracted business and
recurring streams for the full 2008 year already stands at £5.7 million.
Furthermore our sales funnel is very active with additional sales closures
expected in the current quarter.
Last year we broke through our internal goal of 100 customers for our core
software platforms. Including new customers secured through the acquisition of
Alignent, by year-end we had 135 licensees. Our recurring revenue base coming
into 2008 was £2.6 million compared to £1.7 million at the start of 2007.
Today, we have 148 licensees and a recurring revenue base of £2.9 million.
In 2007 we acquired Alignent Software, extending our solution to integrate and
synchronize product planning and product development execution - an industry
first. The acquisition also brought Sopheon immediate credibility in the
aerospace, defense and high-tech markets.
At the turn of the year we introduced the most significant new release of
Accolade in six years, offering functionality that positions the product for
the heavy manufacturing markets. AMR Research recently identified Sopheon as
the most mature product portfolio management offering in the market today.
We have yet to see a major impact on our market from uncertainties in the
global economy. Accordingly, whilst we exercise a degree of caution in our
business management and investment decisions, we remain positive about the
outlook for the remainder of the year."
For further information contact:
Barry Mence, Chairman Sopheon plc + 44 (0) 1483 685 735
Arif Karimjee, CFO
Vikki Krause Hansard Communications + 44 (0) 207 245 1100
+ 44 (0) 7957 203 685
Claire Verhagen Citigate First Financial + 31 (0) 205 754 010
David Newton Seymour Pierce + 44 (0) 207 107 8000
About Sopheon
Sopheon (LSE: SPE) is an international provider of software and services that
help organizations improve the business impact of product innovation. Sopheon's
solutions automate and govern the innovation process, enabling companies to
increase revenue and profits from new products. Sopheon is listed on the AIM
Market of the London Stock Exchange and on the Euronext in the Netherlands. For
more information, please visit www.sopheon.com.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.